• EDITORIAL POLICY
  • ABOUT US
Thursday, April 15, 2021
PML Daily
  • Home
  • NEWS
    • Politics
    • Education
    • Regional
    • Africa
    • World
  • INVESTIGATIONS
    • National Archives
    • Special Reports
  • OpEd
  • BUSINESS
    • Agriculture
    • Tech
    • Finance
  • FEATURES
    • Health
    • Tours & Travel
    • Entertainment
    • Society
  • COLUMNISTS
    • The Suited Penguin
  • SPORT
  • Jobs
  • Magazines
No Result
View All Result
  • Home
  • NEWS
    • Politics
    • Education
    • Regional
    • Africa
    • World
  • INVESTIGATIONS
    • National Archives
    • Special Reports
  • OpEd
  • BUSINESS
    • Agriculture
    • Tech
    • Finance
  • FEATURES
    • Health
    • Tours & Travel
    • Entertainment
    • Society
  • COLUMNISTS
    • The Suited Penguin
  • SPORT
  • Jobs
  • Magazines
No Result
View All Result
PML Daily
No Result
View All Result
Home NEWS

WHO calls for equitable access to future COVID-19 vaccines in Africa

JAVIRA SSEBWAMI | PML Daily Staff Writer by JAVIRA SSEBWAMI | PML Daily Staff Writer
July 9, 2020
in NEWS
0 0
8
SHARES
352
VIEWS
FacebookWhatsAppTwitter
simbatelecom simbatelecom simbatelecom
WHO has developed new guidelines on immunization in the context of COVID-19 that stress the need for a dynamic, approach (PHOTO/File)

KAMPALA – The World Health Organization (WHO) in Africa joined immunization experts in urging the international community and countries in Africa to take concrete actions to ensure equitable access to COVID-19 vaccines, as researchers around the world race to find effective protection against the virus.

“It is clear that as the international community comes together to develop safe and effective vaccines and therapeutics for COVID-19, equity must be a central focus of these efforts,” said Dr. Matshidiso Moeti, WHO Regional Director for Africa. “Too often, African countries end up at the back of the queue for new technologies, including vaccines. These life-saving products must be available to everyone, not only those who can afford to pay.”

WHO and partners launched the Access to COVID-19 Tools (ACT) Accelerator to speed up the development, production, and equitable access to COVID-19 diagnostics, therapeutics, and vaccines. It brings together leaders of government, global health organizations civil society groups, businesses, and philanthropies to form a plan for an equitable response to the COVID-19 pandemic. WHO is collaborating with Gavi, the Vaccine Alliance, and the Coalition for Epidemic Preparedness Innovations (CEPI) to ensure a fair allocation of vaccines to all countries, aiming to deliver 2 billion doses globally for high-risk populations, including 1 billion for low and middle-income countries.

The African Union has endorsed the need for Africa to develop a framework to actively engage in the development and access to COVID-19 vaccines. Countries can take steps now that will strengthen health systems, improve immunization delivery, and pave the way for the introduction of a COVID-19 vaccine. These include: mobilizing financial resources; strengthening local vaccine manufacturing, and regulatory, supply and distribution systems; building workforce skills and knowledge; enhancing outreach services; and listening to community concerns to counter misinformation.

Globally, there are nearly 150 COVID-19 vaccine candidates and currently, 19 are in clinical trials. South Africa is the first country on the continent to start a clinical trial with the University of Witwatersrand in Johannesburg testing a vaccine developed by the Oxford Jenner Institute in the United Kingdom. The South African Ox1Cov-19 Vaccine VIDA-Trial is expected to involve 2000 volunteers aged 18–65 years and include some people living with HIV. The vaccine is already undergoing trials in the United Kingdom and Brazil with thousands of participants.

According to the African Academy of Sciences, only 2% of clinical trials conducted worldwide occur in Africa. It is important to test the COVID-19 vaccine in countries where it is needed to ensure that it will be effective. With more than 215 000 cases, South Africa accounts for 43% of the continent’s total cases. Clinical trials must be performed according to international and national scientific and ethical standards, which include informed consent for any participant.

“I encourage more countries in the region to join these trials so that the contexts and immune response of populations in Africa are factored into studies,” said Dr. Moeti. “Africa has the scientific expertise to contribute widely to the search for an effective COVID-19 vaccine. Indeed, our researchers have helped develop vaccines that provide protection against communicable diseases such as meningitis, Ebola, yellow fever, and a number of other common health threats in the region.”

Earlier, this month WHO Africa’s principal advisory group on immunization policies and programs – the African Regional Immunization Technical Advisory Group (RITAG) – also noted the need to ensure equitable access to COVID-19 and other vaccines in the region.

“As the world focuses on finding a vaccine for COVID-19, we must ensure people do not forget that dozens of lifesaving vaccines already exist. These vaccines should reach children everywhere in Africa – no one can be left behind,” said Professor Helen Rees, Chair of the RITAG.

Initial analysis of the impact of the COVID-19 pandemic on immunization in the African Region suggests that millions of African children are likely to be negatively impacted, as routine immunization services and vaccination campaigns for polio, cholera, measles, yellow fever, meningitis, and human papillomavirus have been disrupted.

Despite these challenges, RITAG members also noted significant milestones and markers of progress. For example, there have been tremendous gains in the fight against wild poliovirus, and the African Region is expected to be officially certified free of wild poliovirus in August 2020. The Democratic Republic of the Congo also announced the end of its 10th Ebola outbreak in eastern DRC, which was the worst in its history. An effective vaccine was a key tool in the response.

Dr. Moeti spoke about COVID-19 vaccine development in Africa during a virtual press conference today organized by APO Group. She was joined by Professor Shabir Madhi, University of Witwatersrand, Principal Investigator of Oxford Covid-19 Vaccine Trial in South Africa; and Professor Pontiano Kaleebu, Director of the MCR/UVRI and LSHTM Ugandan Research Unit. The briefing was streamed on more than 300 African news sites as well as the WHO Regional Office for Africa’s Twitter and Facebook accounts.

Comments

Tags: immunisationtop

Related Posts

Power distributor Umeme has reached out to customers about the recovery of electricity arrears for the benefits enjoyed by some customers in December 2020 (PHOTO/File)
BUSINESS

Umeme explains recovery of Yaka units

April 14, 2021
29
Micheal Azira is a Ugandan professional footballer who plays for New Mexico United (PHOTO/Courtesy).
SPORT

Uganda Cranes future in turmoil as midfielder Azira quits national duties days after skipper Onyango, defender Hassan Wasswa retired

April 14, 2021
40
Legal Service and Boards Affairs Patience Rubagumya who represented Commissioner General URA receiving the items (PHOTO/Courtesy).
BUSINESS

URA gets trade facilitation boost for marine and border surveillance operations

April 14, 2021
49
Mr Bizibu the Executive Secretary of the Departed Asians Property Custodian Board is caught up in another dispute (PHOTO/File).
NEWS

CID confirms Asians properties board top officials under probe over UGX1.6b property scam against city investor

April 14, 2021
86
Carrefour Uganda, received the Gold Award for Best Shopping Supermarket at this year’s Consumers Choice Awards (PHOTO/Courtesy).
BUSINESS

Carrefour hypermarket wins maiden consumer choice award – best shopping supermarket category

April 14, 2021
47
Minister of Finance, Planning and Economic Development Matia Kasaija
NEWS

Govt tables UGX 41.2 trillion budget for next financial year

April 14, 2021
68

Advertisement






 

 

About

The PML Daily, published via www.pmldaily.com is a publication of Post Media Ltd, a professional Digital/New Media company in Uganda.

Follow us

KIU

  • EDITORIAL POLICY
  • ABOUT US

© 2021 PMLDAILY.COM.

No Result
View All Result
  • Home
  • NEWS
    • Politics
    • Education
    • Regional
    • Africa
    • World
  • INVESTIGATIONS
    • National Archives
    • Special Reports
  • OpEd
  • BUSINESS
    • Agriculture
    • Tech
    • Finance
  • FEATURES
    • Health
    • Tours & Travel
    • Entertainment
    • Society
  • COLUMNISTS
    • The Suited Penguin
  • SPORT
  • Jobs
  • Magazines

© 2021 PMLDAILY.COM.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In